Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

Abstract

The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can more accurately estimate the disease burden by detecting infections missed by the limited testing performed to date. Here, we describe the validation of a coronavirus antigen microarray containing immunologically significant antigens from SARS-CoV-2, in addition to SARS-CoV, MERS-CoV, common human coronavirus strains, and other common respiratory viruses. A comparison of antibody profiles detected on the array from control sera collected prior to the SARS-CoV-2 pandemic versus convalescent blood specimens from virologically confirmed COVID-19 cases demonstrates near complete discrimination of these two groups, with improved performance from use of antigen combinations that include both spike protein and nucleoprotein. This array can be used as a diagnostic tool, as an epidemiologic tool to more accurately estimate the disease burden of COVID-19, and as a research tool to correlate antibody responses with clinical outcomes.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 17

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1002/jmv.25822

2. 2.
   Laboratory Diagnosis of COVID-19: Current Issues and Challenges · 2020

   No notice
3. 3.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1093/cid/ciaa344

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1016/s1473-3099(20)30196-1

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1128/jcm.00461-20

6. 6.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1186/1471-2334-13-433

7. 7.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1093/infdis/jit609

8. 8.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1073/pnas.0408782102

9. 9.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.3791/59973

10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.2807/1560-7917.es2013.18.14.20441

11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.jcv.2009.02.011

12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.envint.2020.105537

13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1002/pmic.201500375

14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/msphere.00592-18

15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1155/2006/152612

16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/s41418-020-0530-3

17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1073/pnas.2005456117

Cited by papers we hold 6

• Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization · 2022
  No notice
• Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California · 2021
  Not checked
• Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection · 2021
  No notice
• ATR-FTIR spectrum analysis of saliva samples from COVID-19 positive patients · 2021
  Not checked
• Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray · 2021
  Not checked
• Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water, Greater Paris, France, 5 March to 23 April 2020 · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.